Literature DB >> 24692190

c-MYC-induced genomic instability.

Alexandra Kuzyk1, Sabine Mai.   

Abstract

MYC dysregulation initiates a dynamic process of genomic instability that is linked to tumor initiation. Early studies using MYC-carrying retroviruses showed that these viruses were potent transforming agents. Cell culture models followed that addressed the role of MYC in transformation. With the advent of MYC transgenic mice, it became obvious that MYC deregulation alone was sufficient to initiate B-cell neoplasia in mice. More than 70% of all tumors have some form of c-MYC gene dysregulation, which affects gene regulation, microRNA expression profiles, large genomic amplifications, and the overall organization of the nucleus. These changes set the stage for the dynamic genomic rearrangements that are associated with cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24692190      PMCID: PMC3968784          DOI: 10.1101/cshperspect.a014373

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  161 in total

1.  Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Authors:  Asa Karlsson; Debabrita Deb-Basu; Athena Cherry; Stephanie Turner; James Ford; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.

Authors:  Andreas Höglund; Kerstin Strömvall; Yongmei Li; Linus Plym Forshell; Jonas A Nilsson
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

4.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.

Authors:  R J Miltenberger; K A Sukow; P J Farnham
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation.

Authors:  Diane R Wonsey; Karen I Zeller; Chi V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

6.  Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.

Authors:  Robert J Rounbehler; Weimin Li; Mark A Hall; Chunying Yang; Mohammad Fallahi; John L Cleveland
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Authors:  Koji Hironaka; Valentina M Factor; Diego F Calvisi; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

8.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

9.  The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest.

Authors:  Julia M Sidorova; Nianzhen Li; Albert Folch; Raymond J Monnat
Journal:  Cell Cycle       Date:  2008-01-04       Impact factor: 4.534

10.  Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic.

Authors:  S Palmieri; P Kahn; T Graf
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  47 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

Review 2.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

3.  Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Guang Zhang; Jingxin Li; Xianning Wu; Xiaoling Ma; Ge Shan; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

4.  O-linked GlcNAcylation elevated by HPV E6 mediates viral oncogenesis.

Authors:  Qinghua Zeng; Rui-Xun Zhao; Jianfeng Chen; Yining Li; Xiang-Dong Li; Xiao-Long Liu; Wei-Ming Zhang; Cheng-Shi Quan; Yi-Shu Wang; Ying-Xian Zhai; Jian-Wei Wang; Mariam Youssef; Rutao Cui; Jiyong Liang; Nicholas Genovese; Louise T Chow; Yu-Lin Li; Zhi-Xiang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

Review 5.  Proteins moonlighting in tumor metabolism and epigenetics.

Authors:  Lei Lv; Qunying Lei
Journal:  Front Med       Date:  2021-01-02       Impact factor: 4.592

Review 6.  Multiple oncogenic roles of nuclear beta-catenin.

Authors:  Raju Kumar; Murali D Bashyam
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

Review 7.  MYC and the control of DNA replication.

Authors:  David Dominguez-Sola; Jean Gautier
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 8.  MYC activation is a hallmark of cancer initiation and maintenance.

Authors:  Meital Gabay; Yulin Li; Dean W Felsher
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 9.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

10.  Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.

Authors:  Nour Ghazzaui; Hussein Issaoui; Mélissa Ferrad; Claire Carrion; Jeanne Cook-Moreau; Yves Denizot; François Boyer
Journal:  Blood Adv       Date:  2020-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.